Skip to main content
Veterinary Medicines

SYNERGIX 26.8 MG/240 MG SPOT-ON SOLUTION FOR VERY SMALL DOGS

Authorised
  • Fipronil
  • Permethrin

Product identification

Medicine name:
SYNERGIX 26.8 MG/240 MG SPOT-ON SOLUTION FOR VERY SMALL DOGS
SYNERGIX 26,8 MG/240 MG SOLUTION POUR SPOT-ON POUR TRES PETITS CHIENS
Active substance:
  • Fipronil
  • Permethrin
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    26.84
    milligram(s)
    /
    1.00
    Pipette
  • Permethrin
    239.80
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Box of 1 single-dose pipette containing 0.44 ml
  • Box of 2 single-dose pipettes containing 0.44 ml
  • Box of 4 single-dose pipettes containing 0.44 ml
  • Box of 6 single-dose pipettes containing 0.44 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfamed
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/9766410 9/2014
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0372/001
Concerned member states:
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 7/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."